Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-18-058305

Options or other derivatives

  • Director acquired 130,465 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Windisch Joerg · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2018-11-09 Grant or award : show line 1 in the form Stock Option (Right to Buy) +130,465 $0.61 $79,975 $0.89 2028-11-09 130,465 130,465 D
Loading xslF345X03/doc4.xml…